Beone Medicines ( Formerly Known as Beigene USA, INC.)
Healthcare/Pharmaceuticals
Based in MA
🤖
AI Overview
With $1.0M in lobbying spend across 17 quarterly filings, Beone Medicines ( Formerly Known as Beigene USA, INC.) is a significant lobbying presence. Their lobbying covers 5 issue areas. Active from 2022 to 2025.
$1.0M
Total Spend
4
Years Active
1
Firms Hired
5
Lobbyists Deployed
5
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $130K |
| 2023 | $240K |
| 2024 | $260K |
| 2025 | $390K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Trade, Medicare/Medicaid, Manufacturing, Pharmacy
- •Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User F
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.